公司资料
Aridis Pharmaceuticals 股价、新闻与催化剂
- 股票代码:
- ARDS
- 交易所:
- NASDAQ
- 行业:
- Biopharma
- 所在地:
- United States
股票表现
0.00 USD (0.00%)
收盘价
最后更新: 2026年9月18日
—
市值
股价为何变动
截至 2026年9月18日，ARDS 股价变化不大，收于 $0.0001。当前新闻监测窗口内未发现新的同公司新闻。
公司概览
业务概览
Aridis Pharmaceuticals is a biotechnology company focused on antibody-based therapies for infectious disease and respiratory infections. Its story is centered on using targeted biologics to tackle stubborn pathogens.
所在地与行业分类
Aridis is headquartered in the United States and listed on NASDAQ. It sits in small-cap anti-infective biotechnology.
商业模式特征
The company depends on clinical validation, regulatory strategy, and the ability to keep a narrow pipeline funded. Investors usually watch proof-of-concept data and partnership interest.
生物医药行业定位
Aridis occupies a niche anti-infective position within biotech. The stock is driven by whether its biologic approach can matter in difficult infection settings.
未来催化剂
- Aridis is largely a legacy / closeout story, with catalysts limited to any strategic or asset-resolution update. The market no longer treats it as a live development name.
近期新闻
新闻标题由机器翻译，详情为英文原文。
相似股票
商业成熟度、治疗领域或催化剂模式相近的同行公司。